Effects of risedronate, alendronate, and minodronate alone or in combination with eldecalcitol on bone mineral density, quality, and strength in ovariectomized rats-Reference-Cited by-同舟云学术

Effects of risedronate, alendronate, and minodronate alone or in combination with eldecalcitol on bone mineral density, quality, and strength in ovariectomized rats

Published:2021-06 Issue: Volume:14 Page:101061
ISSN:2352-1872
Container-title:Bone Reports
language:en
Short-container-title:Bone Reports

Author:

Yano Tetsuo,Ito Teppei,Kanehira Yuya,Yamada Mei,Kimura-Suda Hiromi,Wagatsuma Hirotaka,Inoue Daisuke

Publisher

Elsevier BV

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Reference37 articles.

1. Optimal methods for processing mineralized tissues for Fourier transform infrared microspectroscopy;Aparicio;Calcif. Tissue Int.,2002

2. The clinical use of vitamin D metabolites and their potential developments: a position statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF);Cianferotti;Endocrine,2015

3. Clinician’s guide to prevention and treatment of osteoporosis;Cosman;Osteoporos. Int.,2014

4. Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee;Dempster;J. Bone Miner. Res.,2013

5. Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates;Dunford;J. Pharmacol. Exp. Ther.,2001

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mouse model of uncoupled bone remodeling upon discontinuation of anti-RANKL antibody therapy;2024-08-27

2. Bone fragility: conceptual framework, therapeutic implications, and COVID-19-related issues;Therapeutic Advances in Musculoskeletal Disease;2022-01